Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Lysyl oxidase expression and inhibition in uveal melanoma.

Abourbih DA, Di Cesare S, Orellana ME, Antecka E, Martins C, Petruccelli LA, Burnier MN Jr.

Melanoma Res. 2010 Apr;20(2):97-106. doi: 10.1097/CMR.0b013e328336edfe.

PMID:
20179655
2.

Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.

Paraoan L, Gray D, Hiscott P, Ebrahimi B, Damato B, Grierson I.

Exp Eye Res. 2006 Oct;83(4):911-9. Epub 2006 Jun 19.

PMID:
16784742
3.

Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.

Postovit LM, Abbott DE, Payne SL, Wheaton WW, Margaryan NV, Sullivan R, Jansen MK, Csiszar K, Hendrix MJ, Kirschmann DA.

J Cell Biochem. 2008 Apr 1;103(5):1369-78.

PMID:
17685448
4.

Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.

All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager MJ, Larsson O.

Invest Ophthalmol Vis Sci. 2002 Jan;43(1):1-8.

PMID:
11773005
5.

Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.

Pavey S, Zuidervaart W, van Nieuwpoort F, Packer L, Jager M, Gruis N, Hayward N.

Melanoma Res. 2006 Aug;16(4):285-96.

PMID:
16845324
6.

Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival.

van Ginkel PR, Gee RL, Shearer RL, Subramanian L, Walker TM, Albert DM, Meisner LF, Varnum BC, Polans AS.

Cancer Res. 2004 Jan 1;64(1):128-34.

7.

A molecular role for lysyl oxidase in breast cancer invasion.

Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K, Hendrix MJ.

Cancer Res. 2002 Aug 1;62(15):4478-83.

8.

Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.

Lederman M, Meir T, Zeschnigk M, Pe'er J, Chowers I.

Curr Eye Res. 2008 Oct;33(10):876-84. doi: 10.1080/02713680802382989.

PMID:
18853322
9.

MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.

El-Shabrawi Y, Ardjomand N, Radner H, Ardjomand N.

J Pathol. 2001 Jun;194(2):201-6.

PMID:
11400149
10.

Immune expression and inhibition of heat shock protein 90 in uveal melanoma.

Faingold D, Marshall JC, Antecka E, Di Cesare S, Odashiro AN, Bakalian S, Fernandes BF, Burnier MN Jr.

Clin Cancer Res. 2008 Feb 1;14(3):847-55. doi: 10.1158/1078-0432.CCR-07-0926.

11.

[HLA class I antigen expression correlates with histological cell type in uveal melanoma].

Dithmar S, Crowder J, Jager MJ, Vigniswaran N, Grossniklaus HE.

Ophthalmologe. 2002 Aug;99(8):625-8. German.

PMID:
12227276
12.

Expression of somatostatin receptors in uveal melanomas.

Ardjomand N, Ardjomand N, Schaffler G, Radner H, El-Shabrawi Y.

Invest Ophthalmol Vis Sci. 2003 Mar;44(3):980-7.

PMID:
12601018
13.

Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.

Vadasz Z, Kessler O, Akiri G, Gengrinovitch S, Kagan HM, Baruch Y, Izhak OB, Neufeld G.

J Hepatol. 2005 Sep;43(3):499-507.

PMID:
16023247
14.

Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.

Blom DJ, Luyten GP, Mooy C, Kerkvliet S, Zwinderman AH, Jager MJ.

Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1865-72.

PMID:
9286277
15.

Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.

Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, Guimond M, Marcucci G.

Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2390-8.

PMID:
12766035
16.

Expression of integrin alpha5beta1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma.

Béliveau A, Bérubé M, Rousseau A, Pelletier G, Guérin SL.

Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2363-72.

PMID:
10892885
17.

Lysyl oxidase expression in bronchogenic carcinoma.

Woznick AR, Braddock AL, Dulai M, Seymour ML, Callahan RE, Welsh RJ, Chmielewski GW, Zelenock GB, Shanley CJ.

Am J Surg. 2005 Mar;189(3):297-301.

PMID:
15792754
18.

Uveal melanoma: no expression of HLA-G.

Hurks HM, Valter MM, Wilson L, Hilgert I, van den Elsen PJ, Jager MJ.

Invest Ophthalmol Vis Sci. 2001 Dec;42(13):3081-4.

PMID:
11726606
19.

Epigenetic inactivation of RASSF1a in uveal melanoma.

Maat W, van der Velden PA, Out-Luiting C, Plug M, Dirks-Mulder A, Jager MJ, Gruis NA.

Invest Ophthalmol Vis Sci. 2007 Feb;48(2):486-90.

PMID:
17251440
20.

Expression of APITD1 is not related to copy number changes of chromosomal region 1p36 or the prognosis of uveal melanoma.

van Gils W, Mensink HW, Kilic E, Vaarwater J, Verbiest MM, Paridaens D, Luyten GP, de Klein A, Brüggenwirth HT.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4919-23.

PMID:
17962439

Supplemental Content

Support Center